A generic formulation of Pfizer’s blockbuster Lipitor (atorvastatin) has been launched in the UK on the first day of its patent expiry.

The arthritis therapeutics market is expected to experience significant growth in coming years, a new report predicts.

A new service to coordinate 24-hour palliative care in Bedfordshire has been commended for improving patients’ experience during the difficult phase of end of life care.

The European Alliance for Access to Safe Medicines (EAASM) has called for the regulation of off-label drug use in Europe to be improved.

Bristol-Myers Squibb’s anti-platelet therapy Plavix (clopidogrel) has become the latest blockbuster to lose patent protection in the US.

Patients are being denied access to treatments on the NHS for life-threatening conditions due to NICE’s prolonged appraisal system, according to a new report.

India and China are set to become the drug industry’s global hubs for Contract Manufacturing Organisations (CMOs).

The UK cabinet’s veto on publication of the NHS transition risk register was an “unjustified” policy change, according to the Information Commissioner.

A new UK pharma company, Adeptio Pharmaceuticals, specialises in developing new drug delivery mechanisms.

Labour leader Ed Miliband has attacked the Government’s handling of the NHS reforms insisting they ignored the views of key healthcare professionals.